Advertisement

Index by author

July 01 1999; volume 48 issue 7

A

  1. Adkison, K

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  2. Agarwal, R K

    1. Effects of glucose intolerance on myocardial function and collagen-linked glycation.
      G F Avendano, R K Agarwal, R I Bashey, M M Lyons, B J Soni, G N Jyothirmayi and T J Regan
      Diabetes 1999 Jul; 48 (7): 1443-1447. https://doi.org/10.2337/diabetes.48.7.1443

  3. Akerblom, H K

    1. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes.
      O Vaarala, M Knip, J Paronen, A M Hämäläinen, P Muona, M Väätäinen, J Ilonen, O Simell and H K Akerblom
      Diabetes 1999 Jul; 48 (7): 1389-1394. https://doi.org/10.2337/diabetes.48.7.1389

  4. Alejandro, R

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  5. Anai, M

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365

  6. Asano, T

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365

  7. Avendano, G F

    1. Effects of glucose intolerance on myocardial function and collagen-linked glycation.
      G F Avendano, R K Agarwal, R I Bashey, M M Lyons, B J Soni, G N Jyothirmayi and T J Regan
      Diabetes 1999 Jul; 48 (7): 1443-1447. https://doi.org/10.2337/diabetes.48.7.1443

B

  1. Bashey, R I

    1. Effects of glucose intolerance on myocardial function and collagen-linked glycation.
      G F Avendano, R K Agarwal, R I Bashey, M M Lyons, B J Soni, G N Jyothirmayi and T J Regan
      Diabetes 1999 Jul; 48 (7): 1443-1447. https://doi.org/10.2337/diabetes.48.7.1443

  2. Becker, D J

    1. Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.
      T J Orchard, G Virella, K Y Forrest, R W Evans, D J Becker and M F Lopes-Virella
      Diabetes 1999 Jul; 48 (7): 1454-1458. https://doi.org/10.2337/diabetes.48.7.1454

  3. Becker, K G

    1. Comparative genetics of type 1 diabetes and autoimmune disease: common loci, common pathways?
      K G Becker
      Diabetes 1999 Jul; 48 (7): 1353-1358. https://doi.org/10.2337/diabetes.48.7.1353

  4. Berho, M

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  5. Binz, J G

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  6. Björklund, A

    1. Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets.
      A Björklund and V Grill
      Diabetes 1999 Jul; 48 (7): 1409-1414. https://doi.org/10.2337/diabetes.48.7.1409

  7. Blanchard, S G

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  8. Brown, H R

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  9. Brown, K K

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  10. Buckingham, R E

    1. The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.
      A B Walker, P D Chattington, R E Buckingham and G Williams
      Diabetes 1999 Jul; 48 (7): 1448-1453. https://doi.org/10.2337/diabetes.48.7.1448

  11. Burkly, L C

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

C

  1. Carroll, R J

    1. Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6.
      H Furukawa, R J Carroll, H H Swift and D F Steiner
      Diabetes 1999 Jul; 48 (7): 1395-1401. https://doi.org/10.2337/diabetes.48.7.1395

  2. Chan, C B

    1. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets.
      C B Chan, P E MacDonald, M C Saleh, D C Johns, E Marbàn and M B Wheeler
      Diabetes 1999 Jul; 48 (7): 1482-1486. https://doi.org/10.2337/diabetes.48.7.1482

  3. Chattington, P D

    1. The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.
      A B Walker, P D Chattington, R E Buckingham and G Williams
      Diabetes 1999 Jul; 48 (7): 1448-1453. https://doi.org/10.2337/diabetes.48.7.1448

  4. Chatzipetrou, M

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  5. Chinookoswong, N

    1. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat.
      N Chinookoswong, J L Wang and Z Q Shi
      Diabetes 1999 Jul; 48 (7): 1487-1492. https://doi.org/10.2337/diabetes.48.7.1487

  6. Cobb, J E

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  7. Colantuoni, V

    1. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.
      F P Mancini, O Vaccaro, L Sabatino, A Tufano, A A Rivellese, G Riccardi and V Colantuoni
      Diabetes 1999 Jul; 48 (7): 1466-1468. https://doi.org/10.2337/diabetes.48.7.1466

  8. Cryer, P E

    1. Hypoglycemia per se stimulates sympathetic neural as well as adrenomedullary activity, but, unlike the adrenomedullary response, the forearm sympathetic neural response is not reduced after recent hypoglycemia.
      D S Paramore, C G Fanelli, S D Shah and P E Cryer
      Diabetes 1999 Jul; 48 (7): 1429-1436. https://doi.org/10.2337/diabetes.48.7.1429

D

  1. de Groot, M

    1. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?
      P De Vos, J F Van Straaten, A G Nieuwenhuizen, M de Groot, R J Ploeg, B J De Haan and R Van Schilfgaarde
      Diabetes 1999 Jul; 48 (7): 1381-1388. https://doi.org/10.2337/diabetes.48.7.1381

  2. De Haan, B J

    1. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?
      P De Vos, J F Van Straaten, A G Nieuwenhuizen, M de Groot, R J Ploeg, B J De Haan and R Van Schilfgaarde
      Diabetes 1999 Jul; 48 (7): 1381-1388. https://doi.org/10.2337/diabetes.48.7.1381

  3. De Vos, P

    1. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?
      P De Vos, J F Van Straaten, A G Nieuwenhuizen, M de Groot, R J Ploeg, B J De Haan and R Van Schilfgaarde
      Diabetes 1999 Jul; 48 (7): 1381-1388. https://doi.org/10.2337/diabetes.48.7.1381

  4. Dvorak, R V

    1. Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women.
      A Tchernof, R D Starling, J D Walston, A R Shuldiner, R V Dvorak, K Silver, D E Matthews and E T Poehlman
      Diabetes 1999 Jul; 48 (7): 1425-1428. https://doi.org/10.2337/diabetes.48.7.1425

E

  1. Egawa, K

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

  2. Evans, R W

    1. Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.
      T J Orchard, G Virella, K Y Forrest, R W Evans, D J Becker and M F Lopes-Virella
      Diabetes 1999 Jul; 48 (7): 1454-1458. https://doi.org/10.2337/diabetes.48.7.1454

F

  1. Faison, W

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  2. Fanelli, C G

    1. Hypoglycemia per se stimulates sympathetic neural as well as adrenomedullary activity, but, unlike the adrenomedullary response, the forearm sympathetic neural response is not reduced after recent hypoglycemia.
      D S Paramore, C G Fanelli, S D Shah and P E Cryer
      Diabetes 1999 Jul; 48 (7): 1429-1436. https://doi.org/10.2337/diabetes.48.7.1429

  3. Fernandez, L A

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  4. Forrest, K Y

    1. Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.
      T J Orchard, G Virella, K Y Forrest, R W Evans, D J Becker and M F Lopes-Virella
      Diabetes 1999 Jul; 48 (7): 1454-1458. https://doi.org/10.2337/diabetes.48.7.1454

  5. Fridkin, M

    1. New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin.
      E Gershonov, Y Shechter and M Fridkin
      Diabetes 1999 Jul; 48 (7): 1437-1442. https://doi.org/10.2337/diabetes.48.7.1437

  6. Fukushima, Y

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365

  7. Funaki, M

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365

  8. Furukawa, H

    1. Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6.
      H Furukawa, R J Carroll, H H Swift and D F Steiner
      Diabetes 1999 Jul; 48 (7): 1395-1401. https://doi.org/10.2337/diabetes.48.7.1395

G

  1. Gao, Z Y

    1. Activation of the sphingomyelinase/ceramide signal transduction pathway in insulin-secreting beta-cells: role in cytokine-induced beta-cell death.
      C D Major, Z Y Gao and B A Wolf
      Diabetes 1999 Jul; 48 (7): 1372-1380. https://doi.org/10.2337/diabetes.48.7.1372

  2. Gershonov, E

    1. New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin.
      E Gershonov, Y Shechter and M Fridkin
      Diabetes 1999 Jul; 48 (7): 1437-1442. https://doi.org/10.2337/diabetes.48.7.1437

  3. Goldberg, J L

    1. Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway.
      X J Sun, J L Goldberg, L Y Qiao and J J Mitchell
      Diabetes 1999 Jul; 48 (7): 1359-1364. https://doi.org/10.2337/diabetes.48.7.1359

  4. Grill, V

    1. Enhancing effects of long-term elevated glucose and palmitate on stored and secreted proinsulin-to-insulin ratios in human pancreatic islets.
      A Björklund and V Grill
      Diabetes 1999 Jul; 48 (7): 1409-1414. https://doi.org/10.2337/diabetes.48.7.1409

H

  1. Hämäläinen, A M

    1. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes.
      O Vaarala, M Knip, J Paronen, A M Hämäläinen, P Muona, M Väätäinen, J Ilonen, O Simell and H K Akerblom
      Diabetes 1999 Jul; 48 (7): 1389-1394. https://doi.org/10.2337/diabetes.48.7.1389

  2. Han, D

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  3. Haneda, M

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

  4. Harlan, D M

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  5. Harrington, W W

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  6. Hashim, M A

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  7. Hauge-Evans, A C

    1. Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets.
      A C Hauge-Evans, P E Squires, S J Persaud and P M Jones
      Diabetes 1999 Jul; 48 (7): 1402-1408. https://doi.org/10.2337/diabetes.48.7.1402

  8. Henke, B R

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  9. Hidaka, H

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

I

  1. Iaria, G

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  2. Ilonen, J

    1. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes.
      O Vaarala, M Knip, J Paronen, A M Hämäläinen, P Muona, M Väätäinen, J Ilonen, O Simell and H K Akerblom
      Diabetes 1999 Jul; 48 (7): 1389-1394. https://doi.org/10.2337/diabetes.48.7.1389

  3. Inukai, K

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365

  4. Inverardi, L

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  5. Iwai, N

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

J

  1. Johns, D C

    1. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets.
      C B Chan, P E MacDonald, M C Saleh, D C Johns, E Marbàn and M B Wheeler
      Diabetes 1999 Jul; 48 (7): 1482-1486. https://doi.org/10.2337/diabetes.48.7.1482

  2. Jones, P M

    1. Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets.
      A C Hauge-Evans, P E Squires, S J Persaud and P M Jones
      Diabetes 1999 Jul; 48 (7): 1402-1408. https://doi.org/10.2337/diabetes.48.7.1402

  3. Jyothirmayi, G N

    1. Effects of glucose intolerance on myocardial function and collagen-linked glycation.
      G F Avendano, R K Agarwal, R I Bashey, M M Lyons, B J Soni, G N Jyothirmayi and T J Regan
      Diabetes 1999 Jul; 48 (7): 1443-1447. https://doi.org/10.2337/diabetes.48.7.1443

K

  1. Kaldor, I

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  2. Kashiwagi, A

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

  3. Katagiri, H

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365

  4. Kenyon, N S

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  5. Kikkawa, R

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

  6. Kikuchi, M

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365

  7. Kim, J

    1. Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q).
      M A Navas, E J Munoz-Elias, J Kim, D Shih and M Stoffel
      Diabetes 1999 Jul; 48 (7): 1459-1465. https://doi.org/10.2337/diabetes.48.7.1459

  8. Kinoshita, M

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

  9. Kirk, A D

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  10. Kliewer, S A

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  11. Knip, M

    1. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes.
      O Vaarala, M Knip, J Paronen, A M Hämäläinen, P Muona, M Väätäinen, J Ilonen, O Simell and H K Akerblom
      Diabetes 1999 Jul; 48 (7): 1389-1394. https://doi.org/10.2337/diabetes.48.7.1389

  12. Kojima, H

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

L

  1. Lehmann, J M

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  2. Lehmann, R

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  3. Lenhard, J M

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  4. Lopes-Virella, M F

    1. Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.
      T J Orchard, G Virella, K Y Forrest, R W Evans, D J Becker and M F Lopes-Virella
      Diabetes 1999 Jul; 48 (7): 1454-1458. https://doi.org/10.2337/diabetes.48.7.1454

  5. Lyons, M M

    1. Effects of glucose intolerance on myocardial function and collagen-linked glycation.
      G F Avendano, R K Agarwal, R I Bashey, M M Lyons, B J Soni, G N Jyothirmayi and T J Regan
      Diabetes 1999 Jul; 48 (7): 1443-1447. https://doi.org/10.2337/diabetes.48.7.1443

M

  1. MacDonald, P E

    1. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets.
      C B Chan, P E MacDonald, M C Saleh, D C Johns, E Marbàn and M B Wheeler
      Diabetes 1999 Jul; 48 (7): 1482-1486. https://doi.org/10.2337/diabetes.48.7.1482

  2. Maegawa, H

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

  3. Major, C D

    1. Activation of the sphingomyelinase/ceramide signal transduction pathway in insulin-secreting beta-cells: role in cytokine-induced beta-cell death.
      C D Major, Z Y Gao and B A Wolf
      Diabetes 1999 Jul; 48 (7): 1372-1380. https://doi.org/10.2337/diabetes.48.7.1372

  4. Mancini, F P

    1. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.
      F P Mancini, O Vaccaro, L Sabatino, A Tufano, A A Rivellese, G Riccardi and V Colantuoni
      Diabetes 1999 Jul; 48 (7): 1466-1468. https://doi.org/10.2337/diabetes.48.7.1466

  5. Marbàn, E

    1. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets.
      C B Chan, P E MacDonald, M C Saleh, D C Johns, E Marbàn and M B Wheeler
      Diabetes 1999 Jul; 48 (7): 1482-1486. https://doi.org/10.2337/diabetes.48.7.1482

  6. Masetti, M

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  7. Matthews, D E

    1. Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women.
      A Tchernof, R D Starling, J D Walston, A R Shuldiner, R V Dvorak, K Silver, D E Matthews and E T Poehlman
      Diabetes 1999 Jul; 48 (7): 1425-1428. https://doi.org/10.2337/diabetes.48.7.1425

  8. Menius, J A

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  9. Mintz, D H

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  10. Mitchell, J J

    1. Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway.
      X J Sun, J L Goldberg, L Y Qiao and J J Mitchell
      Diabetes 1999 Jul; 48 (7): 1359-1364. https://doi.org/10.2337/diabetes.48.7.1359

  11. Mook, R

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  12. Munoz-Elias, E J

    1. Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q).
      M A Navas, E J Munoz-Elias, J Kim, D Shih and M Stoffel
      Diabetes 1999 Jul; 48 (7): 1459-1465. https://doi.org/10.2337/diabetes.48.7.1459

  13. Muona, P

    1. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes.
      O Vaarala, M Knip, J Paronen, A M Hämäläinen, P Muona, M Väätäinen, J Ilonen, O Simell and H K Akerblom
      Diabetes 1999 Jul; 48 (7): 1389-1394. https://doi.org/10.2337/diabetes.48.7.1389

N

  1. Nakamura, Y

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

  2. Navas, M A

    1. Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q).
      M A Navas, E J Munoz-Elias, J Kim, D Shih and M Stoffel
      Diabetes 1999 Jul; 48 (7): 1459-1465. https://doi.org/10.2337/diabetes.48.7.1459

  3. Nieuwenhuizen, A G

    1. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?
      P De Vos, J F Van Straaten, A G Nieuwenhuizen, M de Groot, R J Ploeg, B J De Haan and R Van Schilfgaarde
      Diabetes 1999 Jul; 48 (7): 1381-1388. https://doi.org/10.2337/diabetes.48.7.1381

  4. Nishio, Y

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

  5. Noble, S A

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  6. Novak, P J

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

O

  1. Ogihara, T

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365

  2. Oka, Y

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365

  3. Oliver, W O

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  4. Onishi, Y

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365

  5. Ono, H

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365

  6. Orchard, T J

    1. Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.
      T J Orchard, G Virella, K Y Forrest, R W Evans, D J Becker and M F Lopes-Virella
      Diabetes 1999 Jul; 48 (7): 1454-1458. https://doi.org/10.2337/diabetes.48.7.1454

P

  1. Paramore, D S

    1. Hypoglycemia per se stimulates sympathetic neural as well as adrenomedullary activity, but, unlike the adrenomedullary response, the forearm sympathetic neural response is not reduced after recent hypoglycemia.
      D S Paramore, C G Fanelli, S D Shah and P E Cryer
      Diabetes 1999 Jul; 48 (7): 1429-1436. https://doi.org/10.2337/diabetes.48.7.1429

  2. Parks, D J

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  3. Paronen, J

    1. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes.
      O Vaarala, M Knip, J Paronen, A M Hämäläinen, P Muona, M Väätäinen, J Ilonen, O Simell and H K Akerblom
      Diabetes 1999 Jul; 48 (7): 1389-1394. https://doi.org/10.2337/diabetes.48.7.1389

  4. Persaud, S J

    1. Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets.
      A C Hauge-Evans, P E Squires, S J Persaud and P M Jones
      Diabetes 1999 Jul; 48 (7): 1402-1408. https://doi.org/10.2337/diabetes.48.7.1402

  5. Ploeg, R J

    1. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?
      P De Vos, J F Van Straaten, A G Nieuwenhuizen, M de Groot, R J Ploeg, B J De Haan and R Van Schilfgaarde
      Diabetes 1999 Jul; 48 (7): 1381-1388. https://doi.org/10.2337/diabetes.48.7.1381

  6. Plunket, K D

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  7. Poehlman, E T

    1. Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women.
      A Tchernof, R D Starling, J D Walston, A R Shuldiner, R V Dvorak, K Silver, D E Matthews and E T Poehlman
      Diabetes 1999 Jul; 48 (7): 1425-1428. https://doi.org/10.2337/diabetes.48.7.1425

Q

  1. Qiao, L Y

    1. Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway.
      X J Sun, J L Goldberg, L Y Qiao and J J Mitchell
      Diabetes 1999 Jul; 48 (7): 1359-1364. https://doi.org/10.2337/diabetes.48.7.1359

R

  1. Ranuncoli, A

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  2. Regan, T J

    1. Effects of glucose intolerance on myocardial function and collagen-linked glycation.
      G F Avendano, R K Agarwal, R I Bashey, M M Lyons, B J Soni, G N Jyothirmayi and T J Regan
      Diabetes 1999 Jul; 48 (7): 1443-1447. https://doi.org/10.2337/diabetes.48.7.1443

  3. Riccardi, G

    1. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.
      F P Mancini, O Vaccaro, L Sabatino, A Tufano, A A Rivellese, G Riccardi and V Colantuoni
      Diabetes 1999 Jul; 48 (7): 1466-1468. https://doi.org/10.2337/diabetes.48.7.1466

  4. Ricordi, C

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  5. Rivellese, A A

    1. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.
      F P Mancini, O Vaccaro, L Sabatino, A Tufano, A A Rivellese, G Riccardi and V Colantuoni
      Diabetes 1999 Jul; 48 (7): 1466-1468. https://doi.org/10.2337/diabetes.48.7.1466

  6. Ruiz, P

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

S

  1. Sabatino, L

    1. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.
      F P Mancini, O Vaccaro, L Sabatino, A Tufano, A A Rivellese, G Riccardi and V Colantuoni
      Diabetes 1999 Jul; 48 (7): 1466-1468. https://doi.org/10.2337/diabetes.48.7.1466

  2. Sakoda, H

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365

  3. Saleh, M C

    1. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets.
      C B Chan, P E MacDonald, M C Saleh, D C Johns, E Marbàn and M B Wheeler
      Diabetes 1999 Jul; 48 (7): 1482-1486. https://doi.org/10.2337/diabetes.48.7.1482

  4. Shah, S D

    1. Hypoglycemia per se stimulates sympathetic neural as well as adrenomedullary activity, but, unlike the adrenomedullary response, the forearm sympathetic neural response is not reduced after recent hypoglycemia.
      D S Paramore, C G Fanelli, S D Shah and P E Cryer
      Diabetes 1999 Jul; 48 (7): 1429-1436. https://doi.org/10.2337/diabetes.48.7.1429

  5. Shechter, Y

    1. New concept for long-acting insulin: spontaneous conversion of an inactive modified insulin to the active hormone in circulation: 9-fluorenylmethoxycarbonyl derivative of insulin.
      E Gershonov, Y Shechter and M Fridkin
      Diabetes 1999 Jul; 48 (7): 1437-1442. https://doi.org/10.2337/diabetes.48.7.1437

  6. Shi, K

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

  7. Shi, Z Q

    1. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat.
      N Chinookoswong, J L Wang and Z Q Shi
      Diabetes 1999 Jul; 48 (7): 1487-1492. https://doi.org/10.2337/diabetes.48.7.1487

  8. Shih, D

    1. Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q).
      M A Navas, E J Munoz-Elias, J Kim, D Shih and M Stoffel
      Diabetes 1999 Jul; 48 (7): 1459-1465. https://doi.org/10.2337/diabetes.48.7.1459

  9. Shuldiner, A R

    1. Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women.
      A Tchernof, R D Starling, J D Walston, A R Shuldiner, R V Dvorak, K Silver, D E Matthews and E T Poehlman
      Diabetes 1999 Jul; 48 (7): 1425-1428. https://doi.org/10.2337/diabetes.48.7.1425

  10. Silver, K

    1. Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women.
      A Tchernof, R D Starling, J D Walston, A R Shuldiner, R V Dvorak, K Silver, D E Matthews and E T Poehlman
      Diabetes 1999 Jul; 48 (7): 1425-1428. https://doi.org/10.2337/diabetes.48.7.1425

  11. Simell, O

    1. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes.
      O Vaarala, M Knip, J Paronen, A M Hämäläinen, P Muona, M Väätäinen, J Ilonen, O Simell and H K Akerblom
      Diabetes 1999 Jul; 48 (7): 1389-1394. https://doi.org/10.2337/diabetes.48.7.1389

  12. Soni, B J

    1. Effects of glucose intolerance on myocardial function and collagen-linked glycation.
      G F Avendano, R K Agarwal, R I Bashey, M M Lyons, B J Soni, G N Jyothirmayi and T J Regan
      Diabetes 1999 Jul; 48 (7): 1443-1447. https://doi.org/10.2337/diabetes.48.7.1443

  13. Squires, P E

    1. Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets.
      A C Hauge-Evans, P E Squires, S J Persaud and P M Jones
      Diabetes 1999 Jul; 48 (7): 1402-1408. https://doi.org/10.2337/diabetes.48.7.1402

  14. Starling, R D

    1. Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women.
      A Tchernof, R D Starling, J D Walston, A R Shuldiner, R V Dvorak, K Silver, D E Matthews and E T Poehlman
      Diabetes 1999 Jul; 48 (7): 1425-1428. https://doi.org/10.2337/diabetes.48.7.1425

  15. Steiner, D F

    1. Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6.
      H Furukawa, R J Carroll, H H Swift and D F Steiner
      Diabetes 1999 Jul; 48 (7): 1395-1401. https://doi.org/10.2337/diabetes.48.7.1395

  16. Stoffel, M

    1. Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q).
      M A Navas, E J Munoz-Elias, J Kim, D Shih and M Stoffel
      Diabetes 1999 Jul; 48 (7): 1459-1465. https://doi.org/10.2337/diabetes.48.7.1459

  17. Sun, X J

    1. Insulin-induced insulin receptor substrate-1 degradation is mediated by the proteasome degradation pathway.
      X J Sun, J L Goldberg, L Y Qiao and J J Mitchell
      Diabetes 1999 Jul; 48 (7): 1359-1364. https://doi.org/10.2337/diabetes.48.7.1359

  18. Swift, H H

    1. Long-term elevation of free fatty acids leads to delayed processing of proinsulin and prohormone convertases 2 and 3 in the pancreatic beta-cell line MIN6.
      H Furukawa, R J Carroll, H H Swift and D F Steiner
      Diabetes 1999 Jul; 48 (7): 1395-1401. https://doi.org/10.2337/diabetes.48.7.1395

T

  1. Tchernof, A

    1. Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women.
      A Tchernof, R D Starling, J D Walston, A R Shuldiner, R V Dvorak, K Silver, D E Matthews and E T Poehlman
      Diabetes 1999 Jul; 48 (7): 1425-1428. https://doi.org/10.2337/diabetes.48.7.1425

  2. Tong, W Q

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  3. Tufano, A

    1. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.
      F P Mancini, O Vaccaro, L Sabatino, A Tufano, A A Rivellese, G Riccardi and V Colantuoni
      Diabetes 1999 Jul; 48 (7): 1466-1468. https://doi.org/10.2337/diabetes.48.7.1466

V

  1. Vaarala, O

    1. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes.
      O Vaarala, M Knip, J Paronen, A M Hämäläinen, P Muona, M Väätäinen, J Ilonen, O Simell and H K Akerblom
      Diabetes 1999 Jul; 48 (7): 1389-1394. https://doi.org/10.2337/diabetes.48.7.1389

  2. Väätäinen, M

    1. Cow's milk formula feeding induces primary immunization to insulin in infants at genetic risk for type 1 diabetes.
      O Vaarala, M Knip, J Paronen, A M Hämäläinen, P Muona, M Väätäinen, J Ilonen, O Simell and H K Akerblom
      Diabetes 1999 Jul; 48 (7): 1389-1394. https://doi.org/10.2337/diabetes.48.7.1389

  3. Vaccaro, O

    1. Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes.
      F P Mancini, O Vaccaro, L Sabatino, A Tufano, A A Rivellese, G Riccardi and V Colantuoni
      Diabetes 1999 Jul; 48 (7): 1466-1468. https://doi.org/10.2337/diabetes.48.7.1466

  4. Van Schilfgaarde, R

    1. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?
      P De Vos, J F Van Straaten, A G Nieuwenhuizen, M de Groot, R J Ploeg, B J De Haan and R Van Schilfgaarde
      Diabetes 1999 Jul; 48 (7): 1381-1388. https://doi.org/10.2337/diabetes.48.7.1381

  5. Van Straaten, J F

    1. Why do microencapsulated islet grafts fail in the absence of fibrotic overgrowth?
      P De Vos, J F Van Straaten, A G Nieuwenhuizen, M de Groot, R J Ploeg, B J De Haan and R Van Schilfgaarde
      Diabetes 1999 Jul; 48 (7): 1381-1388. https://doi.org/10.2337/diabetes.48.7.1381

  6. Virella, G

    1. Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study.
      T J Orchard, G Virella, K Y Forrest, R W Evans, D J Becker and M F Lopes-Virella
      Diabetes 1999 Jul; 48 (7): 1454-1458. https://doi.org/10.2337/diabetes.48.7.1454

W

  1. Wagner, J L

    1. Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154.
      N S Kenyon, L A Fernandez, R Lehmann, M Masetti, A Ranuncoli, M Chatzipetrou, G Iaria, D Han, J L Wagner, P Ruiz, M Berho, L Inverardi, R Alejandro, D H Mintz, A D Kirk, D M Harlan, L C Burkly and C Ricordi
      Diabetes 1999 Jul; 48 (7): 1473-1481. https://doi.org/10.2337/diabetes.48.7.1473

  2. Walker, A B

    1. The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.
      A B Walker, P D Chattington, R E Buckingham and G Williams
      Diabetes 1999 Jul; 48 (7): 1448-1453. https://doi.org/10.2337/diabetes.48.7.1448

  3. Walston, J D

    1. Obesity-related phenotypes and the beta3-adrenoceptor gene variant in postmenopausal women.
      A Tchernof, R D Starling, J D Walston, A R Shuldiner, R V Dvorak, K Silver, D E Matthews and E T Poehlman
      Diabetes 1999 Jul; 48 (7): 1425-1428. https://doi.org/10.2337/diabetes.48.7.1425

  4. Wang, J L

    1. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat.
      N Chinookoswong, J L Wang and Z Q Shi
      Diabetes 1999 Jul; 48 (7): 1487-1492. https://doi.org/10.2337/diabetes.48.7.1487

  5. Wheeler, M B

    1. Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets.
      C B Chan, P E MacDonald, M C Saleh, D C Johns, E Marbàn and M B Wheeler
      Diabetes 1999 Jul; 48 (7): 1482-1486. https://doi.org/10.2337/diabetes.48.7.1482

  6. Williams, G

    1. The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats.
      A B Walker, P D Chattington, R E Buckingham and G Williams
      Diabetes 1999 Jul; 48 (7): 1448-1453. https://doi.org/10.2337/diabetes.48.7.1448

  7. Willson, T M

    1. A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
      K K Brown, B R Henke, S G Blanchard, J E Cobb, R Mook, I Kaldor, S A Kliewer, J M Lehmann, J M Lenhard, W W Harrington, P J Novak, W Faison, J G Binz, M A Hashim, W O Oliver, H R Brown, D J Parks, K D Plunket, W Q Tong, J A Menius, K Adkison, S A Noble and T M Willson
      Diabetes 1999 Jul; 48 (7): 1415-1424. https://doi.org/10.2337/diabetes.48.7.1415

  8. Wolf, B A

    1. Activation of the sphingomyelinase/ceramide signal transduction pathway in insulin-secreting beta-cells: role in cytokine-induced beta-cell death.
      C D Major, Z Y Gao and B A Wolf
      Diabetes 1999 Jul; 48 (7): 1372-1380. https://doi.org/10.2337/diabetes.48.7.1372

Y

  1. Yasuda, H

    1. The 3'-untranslated region polymorphism of the gene for skeletal muscle-specific glycogen-targeting subunit of protein phosphatase 1 in the type 2 diabetic Japanese population.
      H Maegawa, K Shi, H Hidaka, N Iwai, Y Nishio, K Egawa, H Kojima, M Haneda, H Yasuda, Y Nakamura, M Kinoshita, R Kikkawa and A Kashiwagi
      Diabetes 1999 Jul; 48 (7): 1469-1472. https://doi.org/10.2337/diabetes.48.7.1469

  2. Yazaki, Y

    1. No correlation of plasma cell 1 overexpression with insulin resistance in diabetic rats and 3T3-L1 adipocytes.
      H Sakoda, T Ogihara, M Anai, M Funaki, K Inukai, H Katagiri, Y Fukushima, Y Onishi, H Ono, Y Yazaki, M Kikuchi, Y Oka and T Asano
      Diabetes 1999 Jul; 48 (7): 1365-1371. https://doi.org/10.2337/diabetes.48.7.1365
Back to top